UTHR Financials
United Therapeutics Corporation - Financial statements & key metrics
Stock Price
$511.30
Market Cap
$23.41B
P/E Ratio
20.4
EPS
$26.44
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$2.88B
Gross Profit
-
Operating Income
-
Net Income
$1.20B
EPS (Diluted)
$24.64
Balance Sheet Highlights
Total Assets
$7.36B
Total Liabilities
$920.00M
Shareholders Equity
-
Cash & Equivalents
$1.70B
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$1.33B
CapEx
-
Free Cash Flow
-
Profitability Metrics
Net Margin
40.6%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is UTHR revenue?
UTHR's most recent quarterly revenue was $2.88B. Annual revenue can be calculated by summing the four most recent quarters.
Is UTHR profitable?
UTHR reported a profit of $1.20B in the most recent quarter. The net profit margin is 40.6%.
What is UTHR market cap?
UTHR has a market capitalization of $23.41B, making it a large-cap stock.
Does UTHR have debt?
View UTHR's balance sheet for debt information.
What is UTHR cash flow?
Cash flow data is available in the full financial statements.